Buscar
Mostrando ítems 1-10 de 57
Interdisciplinary approach to treat dyskeratosis congenita associated with severe aplastic anemia: A case report
(2006-03-01)
This paper reports on a 4-year-old male who had dyskeratosis congenita and who acquired severe aplastic anemia. The patient developed hyperpigmentation of the face, neck and chest region, arms, shoulders and legs. In ...
Interdisciplinary approach to treat dyskeratosis congenita associated with severe aplastic anemia: A case report
(2006-03-01)
This paper reports on a 4-year-old male who had dyskeratosis congenita and who acquired severe aplastic anemia. The patient developed hyperpigmentation of the face, neck and chest region, arms, shoulders and legs. In ...
Acquired hemoglobin H disease in a patient with aplastic anemia evolving into acute myeloid leukemia
(Associação Paulista de Medicina - APM, 2004-12-01)
CONTEXT: The prognosis of severe aplastic anemia has improved since the introduction of bone marrow transplantation and treatment with antithymocyte globulin. In contrast to the success of these protocols, studies with ...
Anemia aplástica adquirida del adulto: Su tratamiento a propósito de dos casos
(Sociedad Médica de Santiago, 2003)
Polymorphisms in TNF and IFNG are associated with clinical characteristics of aplastic anemia in Argentinean population
(Taylor & Francis Ltd, 2015-06-24)
The impaired hematopoiesis in acquired aplastic anemia (AA) results from immune-mediated mechanisms. We characterized polymorphisms implicated in controlling type-1 cytokine production in 69 patients with AA. Our data ...
A retrospective comparison of cyclophosphamide plus antithymocyte globulin with cyclophosphamide plus busulfan as the conditioning regimen for severe aplastic anemia
(Associação Brasileira de Divulgação Científica, 2009-03-01)
Allogeneic hematopoietic stem cell transplantation (AHSCT) is the treatment of choice for young patients with severe aplastic anemia (SAA). The association of antithymocyte globulin (ATG) and cyclophosphamide (CY) is the ...
Caracterización de los clones HPN en pacientes con anemia aplásica
(2014)
Objetivo: Describir las características demográfica y clínicas los pacientes con anemia aplásica estudiados para HPN y las características de los clones HPN en estos pacientes. Metodología: Estudio descriptivo, ...